Tocilizumab Treatment in Patients With COVID-19
Clinical trial NCT04363853 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04363853
- Sponsor
- Instituto Nacional de Cancerologia de Mexico
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-01
- Primary completion
- 2026-12-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.